AzTrials
AzTrials

Pain ManagementNCT05399199

Virtual Reality Distraction During Arteriovenous Fistula Puncture

A study testing virtual reality distraction in people with Pain Management and Hemodialysis, run by Mansoura University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The cannulation of arteriovenous fistula is a painful procedure in hemodialysis patients. Previous studies have shown the effectiveness of virtual reality in reducing pain during needle-related procedures Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Pain Management, Hemodialysis, Virtual Reality
What is being tested?
virtual reality distraction
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
93 participants
Where
1 siteEgypt
Study dates
5 Jun 2022to 15 Feb 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • patients who are under- going conventional hemodialysis three times a week
  • hemodialysis period of one month or more
  • having a healthy AVF access with good function
  • welling to participate in study

Who cannot join

  • patients who have psychiatric diseases
  • panic disorder, anxiety disorder
  • dysfunctional fistula
  • vertigo, issues with sight, hearing, or perception
  • or use painkillers within three hours before hemodialysis

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Nursing Mansoura University

    Al Mansurah

Other trials in Egypt

About this study

Official title: The Effect of Virtual Reality Distraction on Pain and Anxiety During Arteriovenous Fistula Puncture Among Hemodialysis Patients: Randomized Controlled Trial

The cannulation of arteriovenous fistula is a painful procedure in hemodialysis patients. Previous studies have shown the effectiveness of virtual reality in reducing pain during needle-related procedures

Read the detailed description

Patients undergoing hemodialysis experience anxiety and pain related to the insertion of hemodialysis needles, estimated 320 times in total per year. The pain experienced is mostly caused by needle insertion into a fistula. Pain control is one of the main nursing tasks. Pain relief leads to the acceptance of the procedure and ultimately enhances the patients' quality of life. The use of virtual reality to reduce pain and anxiety during the arteriovenous fistula cannulation procedure is based on the concept that the perception of pain can be controlled because an individual is able to process only a limited amount of information at once. As such, the use of virtual reality during painful procedures may serve as a distraction.

Being tested
virtual reality distraction
Medical subject headings
Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • virtual reality distractionProcedure or surgery

    study group patients will view VR scene for 6 minutes before puncture .It involves a soothing nature experience and calming background music. Patients in intervention group will not able to see the puncture procedure due to the VR glasses.

Study groups in NCT05399199
Study groupRoleWhat they receive
study groupExperimentalNot described
Receives: Procedure: virtual reality distraction
control groupNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change in patients pain scores

    visual analogue scale which consists of a vertical line 100 mm long, one end of the line reads "No pain" and at the other is "Unbearable pain

    Measured: will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)

  2. change in patients anxiety scores

    STAI includes two subscales with 20 items each that assess state and trait anxiety .The State Anxiety Scale requires individuals to describe their feelings at a specific moment under specific circumstances, while the Trait Anxiety Scale requires them to describe the way they feel in general.

    Measured: will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)

Secondary outcomes (6)
  1. change in patients satisfaction score

    . The patients will be asked to rate procedure satisfaction placing a mark on a 100-mm vertical visual analogue scale

    Measured: will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)

  2. change in patients heart rate

    checklist will be used to assess heart rate after puncture

    Measured: will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)

  3. change in patients respiratory rate

    checklist will be used to assess respiratory rate after puncture

    Measured: will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)

  4. change in patients systolic blood pressure

    checklist will be used to assess systolic blood pressure after puncture

    Measured: will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)

  5. change in patients diastolic blood pressure

    checklist will be used to assess diastolic blood pressure after puncture

    Measured: will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)

  6. change in patients Oxygen saturation (SpO2)

    checklist will be used to assess Oxygen saturation after puncture

    Measured: will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jun 2022
  2. Study start5 Jun 2022
  3. Primary completion30 Nov 2022
  4. Study completion15 Feb 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
93 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05399199
Sponsor's protocol ID
mansU
Status last verified
Oct 2022
First submitted
22 May 2022
Last updated
21 Feb 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing virtual reality distraction in people with Pain Management and Hemodialysis, run by Mansoura University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change in patients pain scores (time frame: will be measured at baseline and immediately after intervention (after 6 minutes of VR distraction)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in